10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
16.31
+0.02 (0.12%)
At close: Dec 31, 2025, 4:00 PM EST
16.01
-0.30 (-1.84%)
After-hours: Dec 31, 2025, 5:49 PM EST
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $2.06 billion as of December 31, 2025. Its market cap has increased by 20.03% in one year.
Market Cap
2.06B
Enterprise Value
1.67B
1-Year Change
20.03%
Ranking
Category
Stock Price
$16.31
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.95B to $2.06B, a decrease of -58.31%. That is a compound annual growth rate of -12.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 2.06B | 18.74% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |